Understanding this pharmacokinetic profile helps patients and healthcare professionals make informed decisions about treatment changes, side effect management, and planning for surgery or pregnancy
Some researchers argue that maintaining a plasma Hcy concentration below 10 mol/L is essential to mitigate the heightened risk of CVD and ischemic heart disease [46]
Cancer Lett 502:133142 Pasini B, Stratakis CA (2009) SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes
The study was designed as a single-centre, home-use trial, running from December 2023 to March 2024 at PCR Corp's Manchester facility
Premature discontinuation or non-adherence to the prescribed regimen could result in unmet therapeutic goals. Remember that the trials followed patients for over a year 68 weeks
Read on to learn about the role of weight in breast cancer, how GLP-1 receptor agonists work, what BCRF researchers are discovering about them, and more